Navigation Links
Relief from Migraine

Participants in a migraine medication study who cheated and took the drug earlier than suggested may have done migraine sufferers everywhere a big favor.//

A new study shows the medication works best when taken at the first sign of pain, rather than waiting until pain is moderate to severe, as was the requirement of the original study.

Previous research on the use of drugs known as serotonin agonists for the treatment of migraine have required patients to take the drugs only when their pain reached moderate to severe levels. However, patients in one study on the drug sumatriptan violated this rule, taking the medication as soon as they felt a migraine coming on. Researchers analyzed their results separately, and noted treatment of mild pain may be a better strategy.

Investigators conducted two identical studies to see if using sumatriptan for mild pain had the desired effects. The first study involved 354 patients and the second involved 337 patients. Patients were randomized to receive either the active drug or a placebo. Results showed significantly better pain control among those taking the active drug in either 50 milligram or 100 milligram doses. Fifty percent of those taking the lower dose and 57 percent taking the higher dose reported they were completely free from pain two hours later, compared to 29 percent of those taking the placebo. At four hours, 61 percent and 68 percent, respectively, were free from pain, compared to 30 percent for the placebo. Similar numbers were found when the researchers measured freedom from both pain and other migraine symptoms at two and four hours.
'"/>




Page: 1

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Relief from common back pain
3. Relief to pregnant women using fertility drugs
4. Relief of pain for suffering patients
5. Relief from cancer pain with anticonvulsants
6. Pain Relief For Osteoarthritis Patients
7. Relief From Migraines
8. Effective Pain Relief For Patients Suffering From Multiple Sclerosis
9. Drug Found To Bring Relief For Individuals With Early Parkinson’
10. Relief For Women Suffering From Fibromyalgia
11. Lemons Could Give Relief For Patients Suffering From Asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: